Research
Metabolic adaptation
SGLT-2 inhibitors and GLP-1 receptor agonists (GLP-1RAs) lead to a decline in body weight ranging from 1.5 to 5 kg.
Practitioners can consider SGLT-2 inhibitors and GLP-1RAs as effective options for weight loss in patients.
StrongSupportsmedium confidence
All studies reported a decline in body weight following treatment with SGLT-2 inhibitors or GLP-1RAs, ranging from 1.5 to 5 kg.
Why this rating
Based on the systematic review of sixteen randomized controlled trials.
Source
The Emerging Role of Injectable Weight Loss Medications in Plastic Surgery: A Systematic Review
Sachin M. Shridharani et al. · Aesthetic Surgery Journal · 2023
systematic_review · n=10492Cited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →